Fig. 2From: Baicalin reduces blood lipids and inflammation in patients with coronary artery disease and rheumatoid arthritis: a randomized, double-blind, placebo-controlled trialProportion of eligible patients maintaining good/moderate EULAR response after treatmentBack to article page